Newsroom
Sorted by: Latest
-
Vertical Aerospace Launches Battery Pilot Production Line for Valo
LONDON & NEW YORK--(BUSINESS WIRE)--Vertical Aerospace (“Vertical” or “the Company”) (NYSE: EVTL), a global aerospace and technology company pioneering electric aviation, today announced that its battery pilot production line is now operational at its Vertical Energy Centre (VEC). Building on proven battery technology The 15,000 sq ft Vertical Energy Centre opened in 2023 and has produced the battery systems used in the Company’s piloted flight testing since 2024. These proprietary batteries ha...
-
Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking place in Denver, Colorado. Presentation Details: Session: S020 New I...
-
Americhem Appoints Kilian Lamprecht as Vice President of Mergers & Acquisitions to Accelerate Strategic Growth
CUYAHOGA FALLS, Ohio--(BUSINESS WIRE)--Americhem, a global leader in polymer solutions, today announced that Kilian Lamprecht has joined the company as Vice President of Mergers & Acquisitions. Lamprecht brings extensive experience in corporate development and integration within global industrial and technology organizations. He will work closely with Americhem’s executive leadership team and investment partner PPC to identify and execute strategic acquisitions, partnerships and portfolio i...
-
Mirecule Expands Strategic FSHD Collaboration with Sanofi
GAITHERSBURG, Md.--(BUSINESS WIRE)--Mirecule expands strategic collaboration with Sanofi on advancement of best-in-class ARC treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...
-
General Mills Reports Fiscal 2026 Third-quarter Results and Reaffirms Full-year Outlook
MINNEAPOLIS--(BUSINESS WIRE)--General Mills, Inc. (NYSE: GIS) today reported results for its third quarter ended February 22, 2026. “We’re reaffirming our fiscal 2026 guidance today, as our focus on executing our Remarkability playbook continued to deliver stronger competitiveness for our brands in the third quarter,” said General Mills Chairman and Chief Executive Officer Jeff Harmening. “We started the year expecting that our investments, divestitures, and unfavorable timing comparisons would...
-
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s CEO, Brent Ashton, with a Question and Answ...
-
Palladyne AI Subsidiary Selected by U.S. Navy to Develop Low Cost Near Hypersonic Missile
SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI Subsidiary Selected by U.S. Navy to Develop Low Cost Near Hypersonic Missile...
-
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced an oral presentation and multiple poster presentations of five abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. Presentation Details: Title: Preclinical assessment of BT552...
-
Perfect Announces Receipt of Preliminary Non-Binding “Going Private” Proposal
NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty, fashion, photo and video creative industries, today announced that its board of directors (the “Board”) has received a preliminary non-binding proposal letter, dated March 18, 2026 (the “Proposal”), from CyberLink International Technology Corp. (“CyberLink”) and Ms. Alice H. Chang, Chairwoman of...
-
KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026
FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) will host a conference call and webcast on Wednesday, March 25, 2026, at 8:30 a.m. ET to review the Company’s eight months fiscal year 2025 financial results and provide a corporate update. The live audio webcast will be accessible on the Investors section of the Company’s website at www.ir.kalvista.com/event-calendar. An archived replay will be available on the site approximately two hours af...